Latest News about BMY
Recent news which mentions BMY
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
December 19, 2024
From Motley Fool
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
December 19, 2024
From Motley Fool
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
December 17, 2024
From Benzinga
Bristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive Pipeline Outlook
December 16, 2024
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
December 16, 2024
From Benzinga
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
December 16, 2024
From Benzinga
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
December 03, 2024
From Benzinga
Why Is Purple Biotech Stock Trading Higher On Monday?
December 02, 2024
From Benzinga
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
November 29, 2024
From Benzinga
3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever
November 29, 2024
From Motley Fool
From Motley Fool
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
From Benzinga
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
November 15, 2024
From Benzinga
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
November 15, 2024
From Motley Fool
2 Beaten-Down Dividend Stocks to Buy and Hold
November 14, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
November 13, 2024
From Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
November 11, 2024
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
November 11, 2024
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
November 11, 2024
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
